Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy

Theoretical Biology and Medical Modelling

Volumn 8, Issue 1, 2011, Pages

  Schneider, Uwe ^a,b   Sumila, Marcin ^a   Robotka, Judith ^a  

^a Radiotherapy Hirslanden AG   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATOMIC BOMB; BIOLOGICAL MODEL; COHORT ANALYSIS; FEMALE; HODGKIN DISEASE; HUMAN; INCIDENCE; JAPAN; MIDDLE AGED; RADIATION DOSE; RADIATION INDUCED NEOPLASM; RADIATION RESPONSE; RISK FACTOR; SURVIVOR;

ADULT; AGED; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; JAPAN; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WEAPONS; RADIOTHERAPY DOSAGE; RISK FACTORS; SURVIVORS;

EID: 79960686404     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-8-27     Document Type: Article

References (29)

1. Solid cancer incidence in atomic bomb survivors: 1958-1998. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K, Radiat Res 2007 168 1 1 64 10.1667/RR0763.1 17722996 (Pubitemid 351292925)
2. Effects of recent changes in Atomic bomb survivor dosimetry on cancer mortality risk estimated. Preston DL, Pierce DA, Shimizu Y, Cullings HM, Fujita S, Funamoto S, Kodama K, Radiat Res 2004 162 377 389 10.1667/RR3232 15447045 (Pubitemid 39388159)
3. Cancer risk estimates for X-rays with regard to organ specific doses, part I: All solid cancers combined. Walsh L, Rühm W, Kellerer AM, Radiat Environ Biophys 2004 43 145 151 10.1007/s00411-004-0248-5 15309386 (Pubitemid 39592779)
4. Cancer risk estimates for -rays with regard to organ specific doses, part II: Site specific solid cancers. Walsh L, Rühm W, Kellerer AM, Radiat Environ Biophys 2004 43 225 231 10.1007/s00411-004-0263-6 15645312 (Pubitemid 40174131)
5. Radiation carcinogenesis modelling for risk of treatment-related second tumours following radiotherapy. Lindsay KA, Wheldon EG, Deehan C, Wheldon TE, Br J Radiol 2001 74 882 529 36 11459732 (Pubitemid 32674214)
6. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Hall EJ, Wuu CS, Int J Radiat Oncol Biol Phys 2003 56 1 83 8 10.1016/S0360-3016(03) 00073-7 12694826 (Pubitemid 36403679)
7. Production and killing of second cancer precursor cells in radiation therapy: in regard to Hall and Wuu (Int J Radiat Oncol Biol Phys 2003;56:83-88). Davis RH, Int J Radiat Oncol Biol Phys 2004 59 3 916 and author reply Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):312-3 10.1016/j.ijrobp.2003.09.076 15183501 (Pubitemid 38748760)
8. Hypofractionated radiotherapy has the potential for second cancer reduction. Schneider U, Besserer J, Mack A, Theor Biol Med Model 2010 7 4 10.1186/1742-4682-7-4 20149259
9. Dose-effect models for risk-relationship to cell survival parameters. Dasu A, Toma-Dasu I, Acta Oncol 2005 44 8 829 35 10.1080/02841860500401159 16332590 (Pubitemid 41780108)
10. The use of risk estimation models for the induction of secondary cancers following radiotherapy. Dasu A, Toma-Dasu I, Olofsson J, Karlsson M, Acta Oncol 2005 44 4 339 47 10.1080/02841860510029833 16120542 (Pubitemid 41021038)
11. Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose. Schneider U, Zwahlen D, Ross D, Kaser-Hotz B, Int J Radiat Oncol Biol Phys 2005 61 5 1510 5 10.1016/j.ijrobp.2004.12.040 15817357 (Pubitemid 40470435)
12. A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy. Schneider U, Kaser-Hotz B, Z Med Phys 2005 15 1 31 7 15830782 (Pubitemid 40460415)
13. Solid tumor risks after high doses of ionizing radiation. Sachs RK, Brenner DJ, Proc Natl Acad Sci USA 2005 102 37 13040 5 10.1073/pnas.0506648102 16150705 (Pubitemid 41324975)
14. Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships. Schneider U, Kaser-Hotz B, Radiat Environ Biophys 2005 44 3 235 9 10.1007/s00411-005-0016-1 16273381 (Pubitemid 41677231)
15. Phenomenological modelling of second cancer incidence for radiation treatment planning. Pfaffenberger A, Schneider U, Poppe B, Oelfke U, Z Med Phys 2009 19 4 236 50 19962082
16. A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach. Shuryak I, Hahnfeldt P, Hlatky L, Sachs RK, Brenner DJ, Radiat Environ Biophys 2009 48 3 263 74 10.1007/s00411-009-0230-3 19536557
17. A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation. Shuryak I, Hahnfeldt P, Hlatky L, Sachs RK, Brenner DJ, Radiat Environ Biophys 2009 48 3 275 86 10.1007/s00411-009-0231-2 19499238
18. Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Schneider U, Walsh L, Radiat Environ Biophys 2008 47 2 253 63 10.1007/s00411-007-0151-y 18157543
19. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007 37 2-4 1 332 18762065
20. United Nations Scientific Committee on the Effects of Atomic Radiation (2006) Effects of ionizing radiation. UNSCEAR, UNSCEAR 2006 Report to the General Assembly, with Scientific Annex United Nations, New York
21. Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula. Schneider U, Med Phys 2009 36 4 1138 43 10.1118/1.3089792 19472619
22. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, van Leeuwen FE, Holowaty EJ, Andersson M, Wiklund T, Joensuu T, van't Veer MB, Stovall M, Gospodarowicz M, Travis LB, J Clin Oncol 2002 20 16 3484 94 10.1200/JCO.2002.09. 038 12177110
23. Dose-response relationship for breast cancer induction at radiotherapy dose. Schneider U, Sumila M, Robotka J, Gruber G, Mack A, Besserer J, Radiat Oncol 2011 6 1 67 10.1186/1748-717X-6-67 21651799
24. Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications. Carmel RJ, Kaplan HS, Cancer 1976 37 6 2813 25 10.1002/1097-0142(197606)37:6<2813::AID-CNCR2820370637>3.0.CO;2-S 949701
25. Radiation therapy in the management of Hodgkin's disease. Hoppe RT, Semin Oncol 1990 6 704 15
26. Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Mauch PM, Kalish LA, Kadin M, Coleman CN, Osteen R, Hellman S, Cancer 1993 71 6 2062 71 10.1002/1097-0142(19930315)71:6<2062::AID- CNCR2820710622>3.0.CO;2-0 8443755 (Pubitemid 23068557)
27. Dose-response relationship for lung cancer induction at radiotherapy dose. Schneider U, Stipper A, Besserer J, Z Med Phys 2010 20 3 206 14 20832008
28. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. Mack TM, Cozen W, Shibata DK, Weiss LM, Nathwani BN, Hernandez AM, Taylor CR, Hamilton AS, Deapen DM, Rappaport EB, N Engl J Med 1995 332 7 413 8 10.1056/NEJM199502163320701 7824015
29. Experimental derivation of relative biological effectiveness of A-bomb neutrons in Hiroshima and Nagasaki and implications for risk assessment. Sasaki MS, Nomura T, Ejima Y, Utsumi H, Endo S, Saito I, Itoh T, Hoshi M, Radiat Res 2008 170 1 101 17 10.1667/RR1249.1 18582156 (Pubitemid 351931192)